Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision entries were updated to v3.3.2 and v3.2.0 was removed, reflecting internal version control rather than substantive changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange Detected- Removed the government funding status notice banner from the page; core study content, eligibility criteria, and results information remain unchanged.SummaryDifference0.4%

- Check39 days agoChange DetectedMinor UI/formatting adjustments were made to the Study Details page without altering core study information such as eligibility criteria, primary outcomes, or enrollment status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedSummary of changes: updated operating-status notice and version bump from v3.1.0 to v3.2.0, with links to official status pages.SummaryDifference2%

- Check75 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

- Check90 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; 'Back to Top' removed.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.